Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model
Open Access
- 29 September 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (9) , e0257986
Abstract
The first symptoms of schizophrenia (SCHZ) are usually observed during adolescence, a developmental period during which first exposure to psychoactive drugs also occurs. These epidemiological findings point to adolescence as critical for nicotine addiction and SCHZ comorbidity, however it is not clear whether exposure to nicotine during this period has a detrimental impact on the development of SCHZ symptoms since there is a lack of studies that investigate the interactions between these conditions during this period of development. To elucidate the impact of a short course of nicotine exposure across the spectrum of SCHZ-like symptoms, we used a phencyclidine-induced adolescent mice model of SCHZ (2.5mg/Kg, s.c., daily, postnatal day (PN) 38-PN52; 10mg/Kg on PN53), combined with an established model of nicotine minipump infusions (24mg/Kg/day, PN37-44). Behavioral assessment began 4 days after the end of nicotine exposure (PN48) using the following tests: open field to assess the hyperlocomotion phenotype; novel object recognition, a declarative memory task; three-chamber sociability, to verify social interaction and prepulse inhibition, a measure of sensorimotor gating. Phencyclidine exposure evoked deficits in all analyzed behaviors. Nicotine history reduced the magnitude of phencyclidine-evoked hyperlocomotion and impeded the development of locomotor sensitization. It also mitigated the deficient sociability elicited by phencyclidine. In contrast, memory and sensorimotor gating deficits evoked by phencyclidine were neither improved nor worsened by nicotine history. In conclusion, our results show for the first time that nicotine history, restricted to a short period during adolescence, does not worsen SCHZ-like symptoms evoked by a phencyclidine-induced mice model.Keywords
Funding Information
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (SEI-260003/001135/2020)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/202.792/2017)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/010.100961/2018)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/202.266/2018)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (304332/2016-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (132524/2019-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (141270/2019-5)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (finance code 001)
This publication has 112 references indexed in Scilit:
- Behavioral, Biochemical, and Molecular Indices of Stress are Enhanced in Female Versus Male Rats Experiencing Nicotine WithdrawalFrontiers in Psychiatry, 2013
- Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective DisorderArchives of General Psychiatry, 2011
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled TrialNeuropsychopharmacology, 2011
- Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive functionProceedings of the National Academy of Sciences, 2011
- Animal models of schizophreniaBritish Journal of Pharmacology, 2011
- Startle reactivity and prepulse inhibition in prodromal and early psychosis: Effects of age, antipsychotics, tobacco and cannabis in a vulnerable populationPsychiatry Research, 2011
- Braking and Accelerating of the Adolescent BrainJournal of Research on Adolescence, 2011
- Promise and Pitfalls of Animal Models of SchizophreniaCurrent Psychiatry Reports, 2010
- Smoking in Schizophrenia: Diagnostic Specificity, Symptom Correlates, and Illness SeveritySchizophrenia Bulletin, 2008
- Dopamine Modulation of Emotional Processing in Cortical and Subcortical Neural Circuits: Evidence for a Final Common Pathway in Schizophrenia?Schizophrenia Bulletin, 2007